Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates

Anika Therapeutics (ANIK) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1,450.00%. A quarter ago, it was expected that this medical technology company would post earnings of $0.02 per share when it actually produced earnings of $0.04, delivering a surprise of +100%.Over the last four ...